Arizona State Retirement System’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.16M | Buy |
23,873
+656
| +3% | +$31.9K | 0.01% | 1026 |
|
2025
Q1 | $790K | Sell |
23,217
-251
| -1% | -$8.54K | 0.01% | 1181 |
|
2024
Q4 | $924K | Buy |
23,468
+239
| +1% | +$9.41K | 0.01% | 1144 |
|
2024
Q3 | $1.09M | Buy |
23,229
+650
| +3% | +$30.5K | 0.01% | 1055 |
|
2024
Q2 | $1.22M | Buy |
22,579
+1,841
| +9% | +$99.4K | 0.01% | 942 |
|
2024
Q1 | $1.41M | Sell |
20,738
-351
| -2% | -$23.9K | 0.01% | 874 |
|
2023
Q4 | $1.32M | Sell |
21,089
-262
| -1% | -$16.4K | 0.01% | 889 |
|
2023
Q3 | $969K | Buy |
21,351
+365
| +2% | +$16.6K | 0.01% | 1011 |
|
2023
Q2 | $1.18M | Sell |
20,986
-565
| -3% | -$31.7K | 0.01% | 928 |
|
2023
Q1 | $975K | Buy |
21,551
+640
| +3% | +$28.9K | 0.01% | 1023 |
|
2022
Q4 | $850K | Buy |
20,911
+915
| +5% | +$37.2K | 0.01% | 1067 |
|
2022
Q3 | $1.31M | Buy |
19,996
+120
| +0.6% | +$7.84K | 0.01% | 790 |
|
2022
Q2 | $1.21M | Buy |
19,876
+3,327
| +20% | +$202K | 0.01% | 861 |
|
2022
Q1 | $1.04M | Buy |
16,549
+142
| +0.9% | +$8.92K | 0.01% | 1049 |
|
2021
Q4 | $1.24M | Sell |
16,407
-104
| -0.6% | -$7.88K | 0.01% | 975 |
|
2021
Q3 | $1.85M | Buy |
16,511
+108
| +0.7% | +$12.1K | 0.02% | 752 |
|
2021
Q2 | $2.66M | Sell |
16,403
-810
| -5% | -$131K | 0.02% | 615 |
|
2021
Q1 | $2.1M | Buy |
17,213
+1,951
| +13% | +$238K | 0.02% | 708 |
|
2020
Q4 | $2.34M | Sell |
15,262
-214
| -1% | -$32.8K | 0.02% | 620 |
|
2020
Q3 | $1.29M | Buy |
15,476
+6,549
| +73% | +$548K | 0.01% | 791 |
|
2020
Q2 | $656K | Buy |
8,927
+1,875
| +27% | +$138K | 0.01% | 977 |
|
2020
Q1 | $299K | Buy |
+7,052
| New | +$299K | 0.01% | 1288 |
|